Furthermore, afamelanotide stimulates BDNF expression in the brain by activating MC4R to mediate neurogenesis and cognitive function in an Alzheimer’s disease animal model [35]. The gene discussed is BDNF; the disease is early-onset autosomal dominant Alzheimer disease.